These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26507307)

  • 21. The incident user design in comparative effectiveness research.
    Johnson ES; Bartman BA; Briesacher BA; Fleming NS; Gerhard T; Kornegay CJ; Nourjah P; Sauer B; Schumock GT; Sedrakyan A; Stürmer T; West SL; Schneeweiss S
    Pharmacoepidemiol Drug Saf; 2013 Jan; 22(1):1-6. PubMed ID: 23023988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rosuvastatin safety: a comprehensive, international pharmacoepidemiology programme.
    Johansson S; Ming EE; Wallander MA; Rodríguez LA; Herings RM; Goettsch WG; González-Pérez A; McAfee AT; Walker AM
    Pharmacoepidemiol Drug Saf; 2006 Jul; 15(7):454-61. PubMed ID: 16733834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of theophylline on prevention of contrast-induced acute kidney injury: a meta-analysis of randomized controlled trials.
    Dai B; Liu Y; Fu L; Li Y; Zhang J; Mei C
    Am J Kidney Dis; 2012 Sep; 60(3):360-70. PubMed ID: 22516682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural experiments and large databases in respiratory and cardiovascular disease.
    Vestbo J
    Eur Respir Rev; 2016 Jun; 25(140):130-4. PubMed ID: 27246589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Network meta-analysis incorporating randomized controlled trials and non-randomized comparative cohort studies for assessing the safety and effectiveness of medical treatments: challenges and opportunities.
    Cameron C; Fireman B; Hutton B; Clifford T; Coyle D; Wells G; Dormuth CR; Platt R; Toh S
    Syst Rev; 2015 Nov; 4():147. PubMed ID: 26537988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methods in epidemiology: observational study designs.
    DiPietro NA
    Pharmacotherapy; 2010 Oct; 30(10):973-84. PubMed ID: 20874034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics and drug utilization patterns of new users of rosuvastatin and other statins in four countries.
    McAfee AT; Rodríguez LA; Goettsch WG; González-Pérez A; Johansson S; Ming EE; Wallander MA; Herings RM
    Minerva Cardioangiol; 2010 Dec; 58(6):611-22. PubMed ID: 21135803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measurement of statin exposure in the absence of information on prescribed doses.
    Romppainen T; Rikala M; Aarnio E; Korhonen MJ; Saastamoinen LK; Huupponen R
    Eur J Clin Pharmacol; 2014 Oct; 70(10):1275-6. PubMed ID: 25146693
    [No Abstract]   [Full Text] [Related]  

  • 30. Validating the effects of drug treatment on blood pressure in the General Practice Research Database.
    Delaney JA; Moodie EE; Suissa S
    Pharmacoepidemiol Drug Saf; 2008 Jun; 17(6):535-45. PubMed ID: 18265414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of high-dose statin pre-treatment and contrast-induced acute kidney injury on follow-up events in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Patti G; Leoncini M; Toso A; Maioli M; Grieco D; Colonna G; Bellandi F; Di Sciascio G
    Int J Cardiol; 2014 Jun; 174(2):440-1. PubMed ID: 24767765
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of self-controlled designs in pharmacoepidemiology.
    Hallas J; Pottegård A
    J Intern Med; 2014 Jun; 275(6):581-9. PubMed ID: 24635348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of propensity score technique to account for exposure-related covariates: an example and lesson.
    Seeger JD; Kurth T; Walker AM
    Med Care; 2007 Oct; 45(10 Supl 2):S143-8. PubMed ID: 17909373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peri-surgical statins lessen acute kidney injury.
    Waikar SS; Brunelli SM
    J Am Soc Nephrol; 2011 May; 22(5):797-9. PubMed ID: 21493777
    [No Abstract]   [Full Text] [Related]  

  • 35. High-Dose Perioperative Atorvastatin and Acute Kidney Injury Following Cardiac Surgery: A Randomized Clinical Trial.
    Billings FT; Hendricks PA; Schildcrout JS; Shi Y; Petracek MR; Byrne JG; Brown NJ
    JAMA; 2016 Mar; 315(9):877-88. PubMed ID: 26906014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A behavioural Bayes approach to the determination of sample size for clinical trials considering efficacy and safety: imbalanced sample size in treatment groups.
    Kikuchi T; Gittins J
    Stat Methods Med Res; 2011 Aug; 20(4):389-400. PubMed ID: 20223784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Observational studies are just as effective as randomized clinical trials.
    Wolfe RA
    Blood Purif; 2000; 18(4):323-6. PubMed ID: 10965075
    [No Abstract]   [Full Text] [Related]  

  • 38. The promise of pharmacoepidemiology in helping clinicians assess drug risk.
    Avorn J
    Circulation; 2013 Aug; 128(7):745-8. PubMed ID: 23940388
    [No Abstract]   [Full Text] [Related]  

  • 39. New-user and prevalent-user designs and the definition of study time origin in pharmacoepidemiology: A review of reporting practices.
    Luijken K; Spekreijse JJ; van Smeden M; Gardarsdottir H; Groenwold RHH
    Pharmacoepidemiol Drug Saf; 2021 Jul; 30(7):960-974. PubMed ID: 33899305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating medication effects outside of clinical trials: new-user designs.
    Ray WA
    Am J Epidemiol; 2003 Nov; 158(9):915-20. PubMed ID: 14585769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.